WEBINAR: From scoping to systematic: Choosing the right literature review for your evidence needs – October 6, 2026
Navigate the literature review spectrum and gain practical insight into selecting the most appropriate review approach for your evidence needs.
Whether informing internal strategy discussions or supporting HTA submissions, literature reviews are used to answer a wide range of evidence needs across the pharmaceutical industry. From scoping and targeted to fully systematic literature reviews, understanding where different methodologies fit along the evidence synthesis spectrum is key to selecting the right approach.
This webinar will explore the spectrum of literature review methodologies, examine how different review types support varying evidence requirements and decision contexts, and discuss their role within integrated evidence generation planning (IEGP) to support more informed evidence decisions across the product lifecycle.
Designed for pharma and biotech professionals who plan, commission, or act on literature reviews, from HEOR and market access to medical affairs and evidence generation leads.
What you will learn
- Become familiar with types of literature reviews and the terminology used to define them.
- Understand how different literature review approaches vary in purpose, rigor, and resource requirements.
- Recognize the trade-offs between breadth, speed, reproducibility, and methodological rigor.
- Identify the strengths, limitations, and appropriate applications of different review types across common use cases.
- Understand how different literature review methodologies fit within IEGP and support varying evidence requirements.
Speakers
Zarmina Khankhel
Senior Director, Evidence Synthesis, Genesis Research Group
Zarmina has 15+ years experience in HEOR & RWE consulting. She focuses on both qualitative (e.g., systematic and non-systematic literature reviews) and quantitative (e.g., feasibility assessment, meta-analysis, indirect treatment comparisons including network meta-analysis) evidence synthesis activities. In her role at Genesis, she leads the Evidence Synthesis team on global and region-specific projects across a wide range of disease areas and on projects supporting various needs including dossier development, data landscape assessment, evidence gap analysis, HTA, internal strategy support, modeling inputs, publication development and strategy, among others.
Samara Ferguson
Vice President, Head of HEOR, Genesis Research Group
Samara has 30+ years of experience in HEOR and market access across consulting and industry roles. Her expertise spans the full spectrum of market access and evidence strategy, including payer evidence generation, value proposition development, global value dossiers, economic modeling, and HTA submissions. In her role at Genesis, she leads the HEOR team, supporting pharmaceutical and biotech companies in communicating asset value across global and regional markets and helping clients navigate complex reimbursement and payer decision-making environments.
Priti Jhingran
Vice President, Head of HEOR Strategy & Partnerships, Genesis Research Group
Priti has 30+ years of experience in the pharmaceutical industry across consulting and industry roles. A recognized leader in market access, HTA, and evidence strategy, she has helped organizations understand evidence needs and develop approaches that inform access and reimbursement decisions across US and global markets. Priti has led enterprise-wide initiatives focused on value, evidence, and outcomes, supported the launch of more than 15 pharmaceutical products, and built high-performing Health Outcomes teams. She is a frequent speaker and author with more than 75 peer-reviewed publications in health economics, policy, and services research.
In association with
If you are interested in partnering with The Evidence Base for future webinars, please contact [email protected].